Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

395
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

391
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
391
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

532
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
532
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

918
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
918
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

972
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
972
Cancer Survival Analysis01:21

Cancer Survival Analysis

855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bevacizumab added to conventional induction chemotherapy for children with high risk neuroblastoma (BRAVEN trial).

Discover oncology·2026
Same author

Role of miRNA in diagnosis of Wilms tumor and neuroblastoma.

Indian journal of cancer·2026
Same author

Validation of the Reticulin Algorithm for Adrenocortical Neoplasms: Assessing Diagnostic Accuracy Across All Age Groups and Histological Subtypes.

Endocrine pathology·2026
Same author

Prognostic value of serum albumin recovery in pediatric cancer patients: insights into cancer-cachexia and survival outcomes.

Pediatric hematology and oncology·2026
Same author

Epigenetic paradigm of DNA methylation for understanding the pathophysiology, diagnostics, and therapeutics in sarcomas.

Epigenomics·2025
Same author

Artificial Intelligence and Large Language Models in the Fight Against Superficial Fungal Infections: Friend or Foe?

Clinical, cosmetic and investigational dermatology·2025

Related Experiment Video

Updated: Apr 22, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Recent Updates on Pediatric Oncological Emergencies and Their Management.

Sharan Shanubhogue1, Shravani Reddy, Ruksana Sidhique P R

  • 1Department of Pediatrics, Division of Pediatric Oncology, All India Institute of Medical Sciences, New Delhi, India.

American Journal of Clinical Oncology
|April 20, 2026
PubMed
Summary
This summary is machine-generated.

Pediatric oncological emergencies are critical, life-threatening events in children with cancer. Prompt recognition and multidisciplinary management, utilizing novel diagnostics and updated guidelines, are key to improving outcomes.

Keywords:
Oncological emergenciesfebrile neutropeniahyperleukocytosisspinal cord compressiontumor lysis syndrome

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

33.8K

Related Experiment Videos

Last Updated: Apr 22, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.1K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

33.8K

Area of Science:

  • Pediatric Oncology
  • Emergency Medicine
  • Hematology-Oncology

Background:

  • Pediatric oncological emergencies are acute, life-threatening complications of childhood cancer and its treatment.
  • These emergencies necessitate prompt recognition and intervention to minimize morbidity and mortality.
  • They are broadly classified into metabolic, structural, hematological, and treatment-related categories.

Purpose of the Study:

  • To review recent advancements and novel insights in the recognition and management of pediatric oncological emergencies.
  • To highlight updated diagnostic tools and therapeutic strategies for these critical conditions.
  • To emphasize the importance of a multidisciplinary approach in managing pediatric cancer crises.

Main Methods:

  • This review synthesizes current literature on pediatric oncological emergencies.
  • It focuses on novel diagnostic modalities such as point-of-care ultrasonography (POCUS) and advanced laboratory markers.
  • Evidence-based management guidelines and recent progress in risk stratification are discussed.

Main Results:

  • Recent progress in risk stratification and early warning systems enhances the ability to anticipate and mitigate oncological crises.
  • Novel diagnostic tools enable faster identification of high-risk pediatric cancer patients.
  • Updated management guidelines offer evidence-based strategies for timely intervention.

Conclusions:

  • Effective management of pediatric oncological emergencies relies on early diagnosis, vigilant monitoring, and a multidisciplinary approach.
  • Advances in diagnostics and supportive care are improving the prognosis for children facing these critical events.
  • Continuous updates in management strategies are crucial for optimizing patient outcomes.